Effectiveness, Safety, and Pharmacokinetics of Biannual Subcutaneous Lenacapavir for PrEP in Adolescents and Young Adults: Findings from Phase 3 Trials PURPOSE 1 and PURPOSE 2
| | | | | | |

Effectiveness, Safety, and Pharmacokinetics of Biannual Subcutaneous Lenacapavir for PrEP in Adolescents and Young Adults: Findings from Phase 3 Trials PURPOSE 1 and PURPOSE 2

Notable Achievements and Developments: Highlights from IAS 2025 in Kigali, Rwanda The 13th IAS Conference on HIV Science (IAS 2025), held from July…